These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37655751)

  • 1. B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease.
    Dolade N; Rayego-Mateos S; Garcia-Carrasco A; Guerin M; Martín-Ventura JL; Ruiz-Ortega M; Tharaux PL; Valdivielso JM
    Clin Sci (Lond); 2023 Sep; 137(17):1409-1429. PubMed ID: 37655751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
    Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC
    Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-situ analysis of mast cells and dendritic cells in coronary atherosclerosis in chronic kidney disease (CKD).
    Wachter DL; Neureiter D; Câmpean V; Hilgers KF; Büttner-Herold M; Daniel C; Benz K; Amann K
    Histol Histopathol; 2018 Aug; 33(8):871-886. PubMed ID: 29616745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes.
    Beddhu S; Boucher RE; Sun J; Balu N; Chonchol M; Navaneethan S; Chertow GM; Townsend R; Haley W; Cheung AK; Conroy MB; Raj DS; Xu D; George T; Yunis R; Wei G; Canton G; Bates J; Chen J; Papademetriou V; Punzi H; Wiggers A; Wright JT; Greene T; Yuan C
    BMC Nephrol; 2021 Feb; 22(1):69. PubMed ID: 33627066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.
    Zeng L; Mathew AV; Byun J; Atkins KB; Brosius FC; Pennathur S
    J Biol Chem; 2018 May; 293(19):7238-7249. PubMed ID: 29581235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
    Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
    Valdivielso JM; Rodríguez-Puyol D; Pascual J; Barrios C; Bermúdez-López M; Sánchez-Niño MD; Pérez-Fernández M; Ortiz A
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1938-1966. PubMed ID: 31412740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis.
    Mathew AV; Zeng L; Atkins KB; Sadri KN; Byun J; Fujiwara H; Reddy P; Pennathur S
    J Biol Chem; 2021; 296():100120. PubMed ID: 33234591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling.
    Nakano T; Katsuki S; Chen M; Decano JL; Halu A; Lee LH; Pestana DVS; Kum AST; Kuromoto RK; Golden WS; Boff MS; Guimaraes GC; Higashi H; Kauffman KJ; Maejima T; Suzuki T; Iwata H; Barabási AL; Aster JC; Anderson DG; Sharma A; Singh SA; Aikawa E; Aikawa M
    Circulation; 2019 Jan; 139(1):78-96. PubMed ID: 30586693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment.
    Blin MG; Bachelier R; Fallague K; Moussouni K; Aurrand-Lions M; Fernandez S; Guillet B; Robert S; Foucault-Bertaud A; Bardin N; Blot-Chabaud M; Dignat-George F; Leroyer AS
    J Mol Cell Cardiol; 2019 May; 130():76-87. PubMed ID: 30928429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.
    Fernández-Laso V; Méndez-Barbero N; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Atherosclerosis; 2017 May; 260():130-137. PubMed ID: 28390291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-24 regulates macrophage behavior and retards atherosclerosis.
    Di Gregoli K; Jenkins N; Salter R; White S; Newby AC; Johnson JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1990-2000. PubMed ID: 24990232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease.
    Valdivielso JM; Bozic M; Galimudi RK; Bermudez-López M; Navarro-González JF; Fernández E; Betriu À
    Nephrol Dial Transplant; 2019 Dec; 34(12):2079-2088. PubMed ID: 30010839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.
    Betriu A; Martinez-Alonso M; Arcidiacono MV; Cannata-Andia J; Pascual J; Valdivielso JM; Fernández E;
    Nephrol Dial Transplant; 2014 Jul; 29(7):1415-22. PubMed ID: 24586070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content.
    Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Östberg T; Yan ZQ; Kuchroo VK; Hansson GK; Wahren-Herlenius M
    Cardiovasc Res; 2018 Jan; 114(1):158-167. PubMed ID: 29016728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation.
    Zhang Z; Xu X; Lu J; Zhang S; Gu L; Fu J; Jin L; Li H; Zhao M; Zhang J; Wu H; Su L; Fu YX; Wang FS
    J Infect Dis; 2011 Jun; 203(11):1668-78. PubMed ID: 21592997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo culture of human atherosclerotic plaques: A model to study immune cells in atherogenesis.
    Lebedeva A; Vorobyeva D; Vagida M; Ivanova O; Felker E; Fitzgerald W; Danilova N; Gontarenko V; Shpektor A; Vasilieva E; Margolis L
    Atherosclerosis; 2017 Dec; 267():90-98. PubMed ID: 29101840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation.
    Chang TT; Yang HY; Chen C; Chen JW
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.